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Abstract
Background: Type 2 diabetes is becoming an epidemic in China. To evaluate the prevalence, clustering of
metabolic risk factors and their impact on type 2 diabetes, we conducted a population-based study in Shanghai,
China’s largest metropolitan area.
Methods: From 2006 to 2007, 2,113 type 2 diabetes cases and 2,458 comparable controls of adults aged 40 to
79 years were enrolled. Demographic, lifestyle, and dietary factors were assessed via standardized questionnaires.
Plasma, red and white blood cells were collected and stored for future studies. Anthropometric indices and
biochemical intermediates (including blood pressure, fasting glucose, glycosylated hemoglobin, and blood lipids)
were measured. The prevalence of metabolic syndrome were also compared following two criteria recommended
by the Chinese Diabetes Society (CDS, 2004) and the National Cholesterol Education Program’s Adult Treatment
Panel III (ATP III, 2002).
Results: Prevalence of metabolic syndrome (62% vs. 15% using CDS criteria) and its individual components, including
obesity (51% vs. 42%), hypertension (54% vs. 41%), hypertriglyceridemia (42% vs. 32%), and low high-density
lipoprotein-cholesterol (HDL) levels (36% vs. 25%) were higher in diabetes cases than controls. Regardless of criteria
used, those with impaired fasting glucose (IFG) had similarly high prevalence of metabolic syndrome as did diabetes
cases. In a multiple logistic regression model adjusted for demographics and lifestyle risk factors, the odds ratios of
diabetes (95% CI) were 1.23 (1.04-1.45) for overweight (28 >= BMI >= 24), 1.81 (1.45-2.25) for obesity (BMI > 28), 1.53
(1.30-1.80) for central obesity (waist circumference > 80 cm for woman or waist circumference > 85 cm for man), 1.36
(1.17-1.59) for hypertension (sbp/dbp >= 140/90 mmHg), 1.55 (1.32-1.82) for high triglycerides (triglycerides > 1.70
mmol/l) and 1.52 (1.23-1.79) for low HDL-C (HDL-C < 1.04 mmol/L).
Conclusions: These data indicate that multiple metabolic risk factors–individually or jointly–were more prevalent in
diabetes patients than in controls. Further research will examine hypotheses concerning the high prevalence of
IFG, family history, and central obesity, aiding development of multifaceted preventive strategies specific to this
population.
Background
In recent decades, rapid industrialization and urbanization
in the People’s Republic of China has led to major changes
in patterns of complex diseases (e.g. type 2 diabetes),
which are rising to epidemic proportions. According to
the World Health Organization (WHO), the number of
patients worldwide with diabetes will reach 366 million by
2030, with 42 million of them residing in China [1], espe-
cially in metropolitan regions. In Shanghai, China’s largest
city, the prevalence of type 2 diabetes in 2006 was ~9%, far
exceeding the average of ~3% nationwide [2]. In 2010,
Yang and colleagues [3] reported that the prevalence of
diabetes in China has now reached 9.7% among adults
(> 20 years old).
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any medium, provided the original work is properly cited.Although metabolic risk factors such as obesity, glu-
cose intolerance, hypertension, and dyslipdemia (high
triglyceride and low high-density lipoprotein-cholesterol)
have become more prevalent, much remains to be
learned about the impact of these risk factors on type 2
diabetes risk in populations that have recently under-
gone marked socioeconomic and nutrition transition.
Compared to Caucasians in Western cultures, for exam-
ple, Chinese people consume much more cereal-based
products, which appear to confer greater risk of type 2
diabetes due to high glycemic index and/or glycemic
load [4]. Moreover, while the clustering of metabolic
risk factors is well recognized among high risk indivi-
duals, few studies have examined whether different defi-
nitions of metabolic syndrome yield similar estimates
for individuals at high risk for diabetes, such as those
with IFG, who are likely to benefit from early interven-
tion strategies.
More recently, genome-wide association studies have
identified some genetic variants for increased type 2 dia-
betes susceptibility among Caucasians [5]. These genetic
variants appeared to exhibit modest effects and may exert
their full impact on diabetes risk in the presence of certain
environmental exposures, making inferences of the genetic
associations to other racial and ethnic populations diffi-
cult. Thus, it is important to identify both environmental
and genetic factors that affect diabetes risk directly in Chi-
nese. To answer many questions in diabetes research that
are of fundamental importance toward the ultimate con-
trol of this epidemic, we conducted a large population-
based case-control study in Shanghai, China. In particular,
we aimed to 1) examine the prevalence and distribution of
risk factors for type 2 diabetes in Chinese adults living in
Shanghai, 2) investigate the risk of metabolic syndrome
among those with impaired fasting glucose and in appar-
ently healthy non-diabetic individuals with emphasis on
comparing MetS prevalence between the CDS and NCEP
ATP III criteria, and 3) generate an epidemiologic
resource to investigate hypotheses relating gene-environ-
ment interactions to type 2 diabetes risk and its complica-
tions in follow-up effort.
Methods
In 2000, the Centers for Disease Control and Prevention of
Pudong and Baoshan districts developed a health registra-
tion system for local residents and subsequently imple-
mented a management system for type 2 diabetic patients
who had been diagnosed according to the World Health
Organization (WHO) criteria [6]. Between December 2006
and August 2007, the total number of registered type 2
diabetic patients was approximately ~3,000 in Pudong and
~3,500 in Baoshan. We randomly chose 6 communities
(by different economic status, three communities each in
Pudong and Baoshan) and contacted 2,401 cases who met
our inclusion criteria (88% responded). Controls were
identified from the population registers using the same
inclusion and exclusion criteria for cases in the same com-
munities from which cases occurred. A total of 3,234 non-
diabetic individuals were randomly selected and invited by
letter or telephone to participate in the study. 76% of these
responded. All eligible type 2 diabetic patients and com-
parable controls were identified to participate in this
Shanghai Diabetes Study (SDS) where dietary, anthropo-
metrical, and biochemical assessments were conducted.
Written informed consents were obtained from all partici-
pants. This study was approved by both local authorities
and the Ethics Committee of Shanghai Institute for Biolo-
gical Sciences (ER-SIBS-250701), and the UCLA Institu-
tional Review Board (UCLA IRB #06-05-096-11).
Participant enrollment and data collection
Of approximately 6,500 type 2 diabetes cases available in
Baoshan and Pudong, 2,113 type 2 diabetes patients
were enrolled in the SDS. They met the following inclu-
sion criteria in the SDS: 40 - 79 years old; of Chinese
Han ethnicity; had resident registration records, and
lived locally >= 5 years. We excluded participants who
had physical disability, severe diseases (e.g. cancer and
stroke) during the previous 6 months, or who were
unable or unwilling to sign the informed consent form.
Aside from the fact that both districts have a diabetes
surveillance system, the two independent sets of cases in
a well-established health-care network were intended to
serve as split-replication samples to each other (to con-
firm any new findings that may emerge from future
genetic studies). The same inclusion and exclusion cri-
teria for cases were also applied to the selection of con-
trols in these two districts, ultimately enrolling 2,458
controls. These apparently healthy were then examined
to determine if they had ever been diagnosed with dia-
betes or if their fasting glucose levels met the WHO cri-
teria for type 2 diabetes diagnosis. 308 individuals were
identified to have impaired fasting glucose (IFG, fasting
plasma glucose levels from 6.1 mmol/L to 6.9 mmol/L).
All enrollees were examined by centrally-trained staff
at clinics for collection of participant information,
including a questionnaire, anthropometric indices and
overnight fasting (>= 8 hours) blood samples.
Lifestyle, dietary, and anthropometric measurements
All participants completed a standardized questionnaire
that included questions about their demographic charac-
teristics, history of chronic diseases, family history of dia-
betes in first-degree relatives, cigarette smoking, alcohol
consumption, and physical activity. Cigarette smoking
was defined as “at least once daily,” alcohol consumption
was defined as “regularly drink more than 50 ml each
time and at least twice/week”.L o w ,m e d i u ma n dh i g h
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work, walking, flower planting and light stretch activity,”
“jogging, swimming and ping-pong” and “hiking, tennis
and exercise in gym” respectively. For diabetes patients,
diabetic symptoms, onset time, and hypoglycemic medi-
cations were also collected.
A food frequency questionnaire (FFQ) was also admi-
nistered to rank participants according to the distribution
of long-term nutrient and food intake in the SDS. The
development and validation of a similar FFQ used for
Han Chinese in Shanghai have been reported previously
[7,8]. In general, the FFQ can reasonably categorize usual
intake of nutrients and food groups among Chinese
adults. Briefly, our FFQ includes 100 food-items in 10
categories (staple foods, meats, aquatic products, beans
and related products, eggs, milks, vegetables, fruits,
pickled vegetables and others). For each food item, parti-
cipants were asked how frequently in reference to the
previous year ("never”, “times per day”, “times per week”,
“times per month”,a n d“times per year”) and the quanti-
ties they consumed the specific item.
All measurements were conducted using a standardized
protocol. After an overnight fast, participants were asked
t os i ta te a s e ,r e s tf o r≥ 5 minutes, and avoid smoking
and drinking alcoholic beverages and coffee prior to the
scheduled appointment. Blood pressure measurements
30 seconds apart were taken from the participant’sr i g h t
arm, using a conventional mercury sphygmomanometer
with appropriate cuff size. The average value of two con-
secutive measurements was recorded. Subjects taking
antihypertensive medications and those with systolic
blood pressure ≥ 140 mm Hg, diastolic blood pressure
≥ 90 mm Hg (WHO/ISH) were defined as hypertensive.
Height (in centimeter, cm), weight (in kilogram, kg),
waist circumference, and hip circumference were mea-
sured after participants took off their shoes, hats, coats,
and sweaters. Waist circumference was measured at the
midpoint between the inferior costal margin and the
superior border of the iliac crest on the midaxillary line
and hip circumference was measured at the maximum
extension of the buttocks. Body mass index (BMI) was
defined as kg/m
2. Following the recommendation by the
Working Group on Obesity in China (International Life
Science Association, 2001), we defined central obesity
using either waist circumference for men >= 85 cm, for
women >= 80 cm or waist-hip ratio <= 0.75, 0.76~0.85,
>= 0.86. BMI was defined as < 24 for normal, 24~28 for
overweight and > 28 for obesity.
Laboratory and biochemical measurements
Fasting blood specimens were collected using vacuum
negative pressure tubes. Blood glucose, glycosylated hemo-
globulin A1C (HbA1c), and lipids were measured using
Roche modular P800 autoanalyzer. All measurements
were performed at the biochemistry and immunology
laboratory of Dongfang Hospital, a teaching affiliate of
Tongji University. The interassay coefficients of variation
were 1.7% for glucose, 3.2% for HbA1c, 1.8% for
triglycerides, 1.7% for total cholesterol, 1.2% for LDL-cho-
lesterol, and 1.3% for HDL-cholesterol. The definition of
abnormal lipid profiles was triglycerides <= 1.70 mmol/L
or HDL-Cholesterol >= 1.04 mmol/L (Chinese Cardiovas-
cular Disease Association, 1997).
Definition of metabolic syndrome
We defined metabolic syndromes using two different cri-
teria (Chinese Diabetes Society, CDS, 2004) [9] and the
National Cholesterol Education Program’s Adult Treat-
ment Panel III (NCEP ATP III, 2002) [10]. According to
the CDS criteria, a participant has metabolic syndrome if
he or she has three or more of the following criteria: BMI
>= 25 kg/m2; fasting glucose >= 110 mg/dl or 2-h plasma
glucose >= 140 mg/dl or diabetes; blood pressure >= 140/
90 mmHg or hypertensive; and triglycerides >= 150 mg/dl
or HDL cholesterol < 35 mg/dl in men or < 39 mg/dl in
women. The metabolic syndrome was also defined by the
NCEP ATPIII, when three or more of the following five
risk determinants were present: waist circumference (men
> 102 cm, women > 88 cm), triglycerides >= 150 mg/dl,
HDL-C (men < 40, women < 50 mg/dl), blood pressure
(>= 130/>= 85 mmHg), and fasting glucose >= 110 mg/dl.
Statistical analysis
We first examined differences in age, sex, education, age at
diagnosis, duration of diabetes, family history and hypogly-
cemia medication by two recruiting districts. The crude
medians (ranges) and prevalence of demographic, lifestyle,
anthropometric, and biochemical characteristics by out-
come status (type 2 diabetes, IFG, and controls) were then
calculated and compared using either Kruskal-Wallis test
(for continuous) and c
2 test (for categorical variables). We
also estimated the prevalence of metabolic syndrome
according to different criteria and its individual compo-
nents by outcome status. Odds ratios (ORs) and 95% con-
fidence intervals (CIs) of type 2 diabetes by demographics
and lifestyle risk factors were calculated in a multiple
logistic regression model. Finally, we calculated ORs and
95% CIs of type 2 diabetes by components of metabolic
syndrome in a multiple logistic regression model adjusted
for age, gender, education, family history, smoking status,
alcohol drinking and leisure physical activities. All p values
were two-sided, and all statistical analyses were conducted
using SAS (version 9.2; SAS institute, Cary, NC).
Results
After data cleaning, 2,050 cases and 2,418 controls’
information were analyzed. Of the 4,468 participants in
the SDS, 1,763 (913 cases and 850 controls) were from
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Baoshan. There were no apparent differences in basic
demographic characteristics between the two districts
(data in Additional File 1), except that participants from
Baoshan reported higher levels of education than did
those from Pudong.
Type 2 diabetes cases had a higher prevalence of tradi-
tional risk factors than controls (Table 1: 31% vs. 11% for
family history of diabetes, 31% vs. 19% for less than
6 years education, 25.1 vs. 24.3 for BMI, 87 vs. 83 for
waist circumference, 0.89 vs. 0.86 for waist-hip ratio,
139 mmHg vs. 130 mmHg for systolic blood pressure,
7.5 mmol/L vs. 4.9 mmol/L for glucose, 7.1% vs. 5.8% for
HBA1C, 1.53 mmol/L vs. 1.35 mmol/L for triglycerides,
1.13 mmol/L vs. 1.22 mmol/L for HDL-cholesterol). The
overall prevalence of metabolic syndrome were 62%
using CDS and 52% using NCEP ATP III in type 2 dia-
betes cases, 43% and 54% in participants with IFG, and
15% and 19% in controls, respectively (Figure 1). Each
individual component of metabolic syndrome was also
more prevalent in diabetes cases than controls (Figure 1).
The occurrence of central obesity, hypertension, hypertri-
glyceridemia, and low HDL-cholesterol was similar
between diabetes cases and IFG individuals.
As expected, education, family history of diabetes and all
components of metabolic syndrome, were each indepen-
dently associated with risk of type 2 diabetes. In a multiple
logistic regression model where all demographics and life-
style variables were simultaneously adjusted, the ORs (95%
CI) were 0.68 (0.48-0.96) for education (> 10 vs. 0-6
years), 5.24 (4.21-6.52)for family history of diabetes (yes vs.
no) (Table 2), 1.23 (1.04-1.45) for overweight (28 >= BMI
>= 24 vs. BMI < 24), 1.81 (1.45-2.25) for obesity (BMI >
28 vs. BMI < 24), 1.53 (1.30-1.80) for central obesity (waist
circumference > 80 cm for woman or waist circumference
> 85 cm for man), 1.36 (1.17-1.59) for hypertension (SBP/
DBP >= 140/90 mmHg), 1.55 (1.32-1.82) for high trigly-
cerides (triglycerides > 1.70 mmol/l) and 1.52 (1.23-1.79)
for low HDL-C (HDL-C < 1.04 mmol/L) (Table 3). These
independent associations between individual risk factor
and diabetes risk did not differ by overall obesity status
(data in Additional File 2).
Discussion
In this large population-based case-control study of Han
Chinese adults living in Shanghai, we have characterized
baseline metabolic risk patterns for type 2 diabetes. Com-
pared to controls, diabetes cases had higher prevalence of
similar risk factors identified in Caucasian populations.
These include lower education levels, family history of
diabetes, cigarette smoking, obesity, high systolic blood
pressure, glycemia and dyslipidemia. Consistent with a
previous report in Caucasians, more than 70% of type 2
diabetes cases in the SDS had an age of diagnosis
between 45 and 65 years [11]. Interestingly, SDS diabetes
cases were five times more likely to have a family history
than controls; such a magnitude of association exceeds
what have previously been reported in population-based
studies of Caucasians, suggesting potential stronger
genetic influences of diabetes risk in Han Chinese. We
have previously examined common genetic variation in
several candidate gene loci (i.e., KCNQ1, KCNJ11,
CDKAL1, and FTO genes) and confirmed some but not
all of their associations with type 2 diabetes in the SDS
[12-15]. Because family history represents the joint con-
tribution of genetic susceptibility and environmental
exposures, further investigation is being planned to test
several emerging hypotheses in the context of gene-gene
or gene-environment interactions.
Our data support the notion that obesity and central
obesity in particular is a strong risk factor for type 2 dia-
betes, a finding that is consistent with those reported pre-
viously in various racial/ethnic populations [16,17].
Globally, it has been estimated that approximately 58% of
type 2 diabetes is attributable to overweight and obesity
and 90% of type 2 diabetes in Western countries is attrib-
uted to weight gain [18]. When lower cutoff points for
BMI and waist circumference were used, Asians appeared
to have a higher prevalence of obesity–especially central
obesity–than Caucasians. Some have proposed that the
B M Ic u t o f fo f2 4k g / m 2b eu s e dt od e f i n eo v e r w e i g h ti n
Chinese adults and that the cutoffs for waist circumfer-
ence be 85 cm for men and 80 cm for women [19]. These
f i n d i n g sa l s os u p p o r tt h a tp r e ventive lifestyle interven-
tions should be targeted at lowering both BMI and
central obesity in Chinese adults.
In the SDS, approximately 54% of type 2 diabetes cases
were also hypertensive, which is higher than the 44%
reported by the study conducted in Shanghai, 2002 [20]
Moreover, a greater proportion of hypertension was also
observed among diabetic individuals with normal weight,
indicating the importance of maintaining normal blood
pressure in non-obese diabetic patients as well.
As expected, dyslipidemia was common among parti-
cipants in the SDS. High TG and low HDL-cholesterol
have been reported as the main phenotypic feature of
dyslipidemia in diabetes, reflecting impaired lipid meta-
bolism [21]. Thus, strategies targeted at lowering TG
levels and increasing HDL-cholesterol, particularly in
non-obese individuals, may be important in reducing
the risk of complications in these Chinese adults.
Among those without apparent diabetes, approximately
13% had impaired fasting glucose levels and displayed a
similar metabolic risk profile as diabetic cases. Such a
high prevalence of IFG portends an increased diabetes
incidence in the coming years because many with IFG
could progress to diabetes should the levels of modifi-
able risk factors remain as they age.
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renal disease, preventable amputations, blindness and
cardiovascular disease, public health measures are
urgently needed to control the rapidly growing health
and social burdens associated with this devastating dis-
ease. As a constellation of metabolic abnormalities, meta-
bolic syndrome is a major determinant or precursor of
type 2 diabetes risk, although there is as yet no consensus
regarding the definitive criteria for different racial and
ethnic populations [22]. The different cutoffs used for
defining obesity, blood pressure, and low HDL choles-
terol levels using the CDS or NCEP ATP III criteria may
explain some of the observed differences in the preva-
lence of metabolic syndrome. Moreover, most previous
studies of diabetes in China have been hospital-based or
utilized convenient sampling strategies without a well-
characterized source population, subjecting findings to
survival and selection biases. The prevalence of MetS
among controls was 15% using the CDS definition, which
was slightly higher than 12% reported previously in
Table 1 Selected demographic, lifestyle, anthropometric, and biochemical characteristics by outcome status among
4,468 participants in the Shanghai Diabetes Study
Characteristics Diabetes
(n = 2,050)
IFG
(n = 308)
Control
(n = 2,110)
P value†
Age (years) * 63 (40-79) 63 (41-79) 59 (40-79) <0.0001
40-49, % 5 4 12 <0.0001
50-59, % 30 32 45
60-69, % 38 39 30
70-79, % 27 25 12
Sex (female, %) 59 65 70 <0.0001
Education (years, %) <0.0001
0-6 31 30 19
7-9 54 50 62
≥10 15 20 19
Family history of diabetes, % 31 12 11 <0.0001
Smoking status, % <0.0001
Current 17 12 14
Never 77 84 83
Past 6 4 4
Alcohol drinking, % <0.0001
Current 13 13 14
Never 83 86 85
Ex-drinker 4 2 1
Leisure physical activity, % 0.02
Low 63 59 67
Moderate 36 41 33
High 1 0 1
BMI (kg/m2)* 25.1 (13.1-43.4) 25.1 (16.5-37.2) 24.3 (15.4-42.1) <0.0001
Waist (cm)* 87 (59-125) 86 (62-119) 83 (56-115) <0.0001
Waist-hip ratio* 0.89 (0.62-1.25) 0.89 (0.68-1.11) 0.86 (0.64-1.10) <0.0001
SBP (mmHg)* 139 (90-218) 140 (90-192) 130 (82-213) <0.0001
DBP (mmHg)* 80 (54-130) 82 (56-110) 80 (48-120) 0.001
Glucose (mmol/l)* 7.5 (2.5-23.1) 6.1 (3.6-7.0) 4.9 (2.1-7.8) <0.0001
HBA1c (%)* 7.1 (0.0-17.5) 6.2 (4.3-8.0) 5.8 (0.0-12.6) <0.0001
Total Cholesterol (mmol/l)* 4.44 (0.93-11.91) 4.43 (2.81-8.53) 4.47 (2.03-11.32) 0.31
Triglycerides (mmol/l)* 1.53 (0.50-22.75) 1.62 (0.46-12.65) 1.35 (0.09-21.10) <0.0001
LDL-Cholesterol (mmol/l)* 2.72 (0.39-6.81) 2.80 (1.31-5.64) 2.75 (0.54-8.64) 0.004
HDL-Cholesterol (mmol/l)* 1.13 (0.00-2.60) 1.10 (0.58-2.05) 1.22 (0.00-2.74) <0.0001
*Data are presented as the median and range (in parentheses).
† P value for difference by outcome status.
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Page 5 of 8Figure 1 Prevalence of metabolic syndrome and its individual components by outcome status among 4,468 participants in the
Shanghai Diabetes Study. * Criteria based on waist circumference according to the Working Group on Obesity in China, International Life
Science Association. 2001: men >= 85 cm and women >= 80 cm. †Criteria according to the World Health Organization/International Society of
Hypertension (WHO/ISH). 1999. ‡Criteria according to Chinese Cardiovascular Disease Association. 1997: Triglycerides <= 1.70 mmol/L; HDL-
Cholesterol >= 1.04 mmol/L. § Criteria according to Chinese Diabetes Society, 2004 (three or more of the following conditions): 1. BMI ≥ 25.0
kg/m2; 2. fasting glucose ≥ 110 mg/dl (6.1 mmol/L) or 2-h plasma glucose ≥ 140 mg/dl (7.8 mmol/L) or diabetes patients; 3. Blood pressure:
≥ 140/90 mmHg or Hypertension patients; 4. triglycerides ≥ 150 mg/dl or HDL cholesterol: men < 35 mg/dl, women < 39 mg/dl. || Criteria
according to National Cholesterol Education Program’s Adult Treatment Panel III (ATP III, 2002) (three or more of the following conditions):
1. abdominal obesity: waist circumference: men > 102 cm, women > 88cm); 2. triglycerides >= 150 mg/dL; 3. HDL cholesterol: men < 40 mg/dL,
women < 50 mg/dL; 4. blood pressure 135/85 mm Hg; 5. fasting glucose >= 110 mg/dL.
Table 2 Odds ratios (ORs) and 95% confidence intervals (CIs) of type 2 diabetes by demographics and lifestyle risk
factors among 4,160 participants in the Shanghai Diabetes Study*
Factors No. of cases/controls OR (crude 95%CI) OR (adjusted 95%)†
Age (years)
40-49 111/257 1.00 1.00
50-59 605/958 1.46 (1.14-1.87) 1.46 (1.07-1.99)
60-69 779/633 2.85 (2.23-3.64) 2.86 (2.09-3.92)
>= 70 555/262 4.90 (3.75-6.40) 4.81 (3.41-6.77)
Sex
female 1,211/1,467 1.00 1.00
male 839/643 1.58 (1.39-1.80) 1.45 (1.17-1.80)
Education (years)
0-6 639/392 1.00 1.00
7-9 1,270/1,569 0.50 (0.43-0.58) 0.72 (0.59-0.86)
>= 10 132/137 0.60 (0.45-0.77) 0.68 (0.48-0.96)
Family history on diabetes
No 1,428/1,889 1.00 1.00
Yes 622/221 3.72 (3.15-4.41) 5.24 (4.21-6.52)
Smoking status
Never 1,279/1,121 1.00 1.00
Past 124/79 1.38 (1.03-1.85) 0.90 (0.63-1.30)
Current 355/278 1.12 (0.94-1.34) 1.04 (0.81-1.34)
Alcohol drinking
Never 1,699/1,786 1.00 1.00
Ex-drinker 73/21 3.66 (2.24-5.96) 2.45 (1.38-4.34)
Current 271/297 0.96 (0.80-1.15) 0.78 (0.62-0.99)
Leisure physical activity
Low 311/289 1.00 1.00
Moderate 990/1,107 0.83 (0.69-1.00) 0.95 (0.76-1.19)
High 748/695 1.00 (0.83-1.2) 0.98 (0.77-1.24)
* All the IFG individuals were excluded from this model.
† Multiple logistic regression model includes all the variables shown in this table simultaneously.
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same criteria [23]. Using the ATP III criteria, the preva-
lence of MetS was 19%, almost identical to that reported
in the Shanghai Men’s Health Study[24]. Of the IFG par-
ticipants and type 2 diabetes cases, 43%, 62% and 54%,
52% had the metabolic syndrome under the CDS and the
NCEP ATP III criteria, respectively. However, it remains
to be determined whether the CDS criteria would provide
more reliable estimate of the metabolic syndrome
amongst Chinese at high risk of type 2 diabetes as com-
pared with other criteria such as the NCEP ATP III cri-
teria [25].
Several limitations of the current study merit consid-
eration. First, our case-control study is retrospective by
design (including prevalence cases) and recall bias is
thus a concern in studying risk behaviors associated
with type 2 diabetes. While we plan to follow all partici-
pants in the SDS to further assess the natural history of
type 2 diabetes and its complications, we note that
many risk factors already identified were similar to
those from well-characterized prospective cohorts of
diverse racial and ethnic groups[26]. Also, we cannot
completely exclude the possibility of selection bias but
such bias may be limited given our response rates and
population-based design.
Conclusions
In summary, this population-based study characterizes
baseline metabolic risk factors for type 2 diabetes
among Chinese adults living Shanghai and generates a
biological resource that enables further investigation of
numerous hypotheses related to both environmental and
genetic exposures in a population that has undergone a
rapid socioeconomic transformation in recent years. Our
initial analysis identifies the high prevalence of IFG and
clustering of several important risk factors (e.g., family
history and central obesity) that will be useful for the
development of effective strategies for type 2 diabetes
prevention in this population.
Additional material
Additional File 1: Basic demographic and clinical characteristics of
4,468 participants (including 2,050 participants with diabetes) from
two different districts in the Shanghai Diabetes Study, China. This
file contains a table of the basic demographic and clinical characteristics
of study participants. *Total number included all participants who
completed questionnaire survey.
Additional File 2: *Multivariable-adjusted odds ratios (ORs) and 95%
confidence intervals (CIs) of type 2 diabetes associated with
modifiable risk factors according to three BMI levels in the
Shanghai Diabetes Study. This file contains a table of the multivariable-
adjusted odds ratios and confidence intervals of type 2 diabetes
associated with modifiable risk factors according to three BMI levels in
the Shanghai Diabetes Study. * Multivariable-adjusted odds ratios and
95% confidence intervals were from the same multiple logistic model
where all the risk factors were simultaneously included.
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